We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

vallosTM

A new allograft that sets the pace for regeneration

Geistlich understands that in certain clinical situations, rapid turnover of new bone is important. That‘s why we‘re bringing you vallos™ demineralized allogeneic granules and fibers that allow you to set the pace for treatment success.

With vallos™ you can expect:

  • Consistent product quality1
  • Verified osteoinductive potential in every lot1
  • Vital bone after 18-20 weeks2

 


 

 

vallos™ and vallos™f

  • Proven regenerative capacity by exhibiting all five elements of bone formation1
  • Delivers osteogenic cells when hydrated with bone marrow aspirate3
  • Promotes structural integrity that supports the integration of implants
  • Second surgical site is not required
  • 5-year shelf life

In addition to the benefits above, vallos™f fibers also provide:

  • Enhanced handling characteristics to provide precise graft placement1
  • 4X higher osteoinductive potential than particulate DBM4

 

Extensive research and collaboration have created a partnership to bring you select allograft materials designed for clinical versatility and success. Demineralized vallos™ and vallos™f offer clinicians more options to enhance their ability to manage a variety of clinical situations.

 

vallos is available as a standalone or with Geistlich vallomix, which conveniently co-packs vallos and Geistlich Bio-Oss®. Together these proven products bring optimal consistency and performance in demanding clinical situations.1-16

 

References:

  1. Data on file, DCI Donor Services Tissue Bank
  2. Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study
  3. Muschler GF. J Bone Joint Surg Am. 1997; 79, 1699-1709
  4. Martin GJ, et. Al. Spine, 1999, 24, 637-645
  5. Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study)
  6. Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study)
  7. Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study)
  8. Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study)
  9. Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study)
  10. Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study)
  11. Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study)
  12. NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research)
  13. Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study)
  14. Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study)
  15. Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study)
  16. Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study)

 

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.